A reliable serum C-peptide index for the selection of an insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes: an analysis from a short-term study with intensive insulin therapy

被引：2
作者：
Suzuki T. [1 ]
Takahashi K. [1 ]
Fujiwara D. [1 ]
Shii M. [1 ]
Takekawa S. [1 ]
Matsuoka T. [1 ]
机构：
[1] Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, 710-8602, Okayama
来源：
Diabetology International | 2016年 / 7卷 / 3期
关键词：
C-peptide; Insulin regimen; Obesity; Type; 2; diabetes;
D O I：
10.1007/s13340-015-0239-6
中图分类号：
学科分类号：
摘要：
Insulin regimens achieving favorable glycemic control in patients with type 2 diabetes are expected to closely relate to residual insulin secretory ability. We herein attempted to identify a reliable C-peptide immunoreactivity (CPR) index as an insulin secretory marker that would contribute to the selection of an appropriate insulin regimen for patients with type 2 diabetes. We near-normalized blood glucose in 246 obese patients with type 2 diabetes using our protocol (which included short-term intensive insulin therapy, IIT), and administered an oral hypoglycemic agent (OHA). Based on responsiveness to OHA, patients were classified into three therapy groups: non-insulin therapy (n = 78), basal-insulin supported oral therapy (BOT) (n = 109), and multiple daily insulin injection (MDI) therapy (n = 59). Glucagon-loading CPR increment (ΔCPR), fasting CPR (FCPR), CPR2h after breakfast (CPR2h), ratio of FCPR to fasting plasma glucose (CPI), CPI2h after breakfast (CPI2h), and secretory unit of islets in transplantation (SUIT) were assessed with receiver operating characteristic (ROC) and multiple logistic analyses to discriminate the MDI group from the other therapy groups. ROC analysis revealed that CPR2h had the greatest area under the curve and specificity. Multiple logistic analysis identified CPR2h and CPI2h as the most significant explanatory variables for identifying patients assigned to the MDI group. A postprandial serum CPR marker such as CPR2h or CPI2h was shown to be the best index for predicting an appropriate insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes. © 2015, The Japan Diabetes Society.
引用
收藏
页码：235 / 243
页数：8
相关论文
共 31 条
  • [1] Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., Et al., Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes, Diabetes Care, 32, pp. 193-203, (2009)
  • [2] Holman R.R., Farmer A.J., Davis M.J., Levy J.C., Darbyshire J.L., Keenan J.F., Et al., Three-year efficacy of complex insulin regimen in type 2 diabetes, N Engl J Med, 361, pp. 1736-1747, (2009)
  • [3] DeFronzo R.A., From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus, Diabetes, 58, pp. 773-795, (2009)
  • [4] Fujiwara D., Takahashi K., Suzuki T., Shii M., Nakashima Y., Takekawa S., Et al., Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: analysis of C-peptide values before and after short-term intensive insulin therapy, J Diabetes Investig, 4, pp. 618-625, (2013)
  • [5] Yamada Y., Fukuda K., Fujimoto S., Hosokawa M., Tsukiyama K., Nagashima K., Et al., SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes, Diabetes Res Clin Pract, 74, pp. 222-226, (2006)
  • [6] Kashiwagi A., Kasuga M., Araki E., Oka Y., Hanafusa T., Itoh H., Et al., International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values, J Diabetes Investig, 3, pp. 39-40, (2012)
  • [7] Hanley J.A., MacNeil B.J., A method of comparing the area under receiver operating characteristic curves derived from the same cases, Radiology, 148, pp. 839-843, (1983)
  • [8] Standards of medical care in diabetes 2012, Diabetes Care, 35, pp. S11-S63, (2012)
  • [9] Funakoshi S., Fujimoto S., Hamasaki A., Fujiwara H., Fujita Y., Ikeda K., Et al., Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes, J Diabetes Investig, 2, pp. 297-303, (2011)
  • [10] Chen H.-S., Wu T.-E., Jap T.-S., Jap T.-S., Hsiao L.-C., Lee S.-H., Et al., Beneficial effects of insulin on glycemic control and β-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy, Diabetes Care, 31, pp. 1927-1932, (2008)
1234